International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Emerging infectious diseases (EIDs) represent a complex and growing threat to global health, with profound implications for public health systems, economies, and societies. The rise of diseases such as COVID-19, Ebola, Zika, and others in recent decades highlights the unpredictable nature of these threats. While some EIDs are newly discovered, others are re-emerging after a period of decline or dormancy, often due to changing environmental, social, and biological factors. Human behavior, including increased global travel, urbanization, deforestation, and climate change, has altered the ecosystems where pathogens thrive, bringing humans and wildlife into closer contact and facilitating the transmission of zoonotic diseases - those that jump from animals to humans.

The underlying causes of EIDs are multifaceted. Rapid urbanization and globalization create dense population centers where diseases can spread quickly. Deforestation and agricultural expansion push humans into previously undisturbed environments, increasing the likelihood of encountering novel pathogens. Meanwhile, climate change alters habitats, leading to the spread of disease vectors like mosquitoes into new regions. The mobility of the modern world through international travel and trade allows these pathogens to spread across continents in a matter of days [1]. In this context, immunodeficiency stands out as a critical factor that heightens individual susceptibility and complicates public health responses.

Immunodeficiency refers to a state in which the body’s immune system is unable to mount an effective response to fight off infections. It can be caused by a range of factors, including genetic conditions, chronic diseases, malnutrition, or medical treatments such as chemotherapy or organ transplants that suppress immune function. As immunodeficient individuals lack robust defenses, they are especially vulnerable to both emerging and re-emerging pathogens. These populations not only experience more severe disease outcomes but also contribute to the persistence and mutation of infectious agents, posing additional risks to the broader community [2].

The relationship between immunodeficiency and EIDs is crucial to understanding how these diseases evolve and spread. Immunodeficient individuals may harbor infections for longer periods, providing a breeding ground for the mutation and adaptation of pathogens. Moreover, their weakened immune systems may struggle to respond to vaccination, limiting the effectiveness of immunization campaigns. This article delves into the intricate interplay between immunodeficiency and EIDs, illustrating how compromised immune responses increase the risks of transmission, mutation, and global spread. Understanding this connection is essential for developing targeted strategies to protect vulnerable populations and curb the spread of emerging infectious diseases.

Description

Immunodeficiency can be broadly classified into two categories: primary and secondary immunodeficiencies. Primary immunodeficiencies (PIDs) are genetic conditions where individuals are born with an impaired immune system. Examples include Severe Combined Immunodeficiency (SCID), characterized by the absence of functioning T and B lymphocytes, and Chronic Granulomatous Disease (CGD), where phagocytes cannot effectively eliminate pathogens [3]. Secondary immunodeficiencies are acquired, often as a result of diseases like HIV/AIDS, cancer treatments, immunosuppressive therapies, or malnutrition.

In the context of EIDs, immunodeficient populations serve as reservoirs for pathogens, potentially facilitating their persistence and evolution. For instance, individuals with weakened immune systems may harbor infections for extended periods, allowing viruses or bacteria to replicate unchecked. This prolonged interaction between pathogen and host increases the likelihood of genetic mutations, which can lead to the emergence of more virulent or drug-resistant strains. The recent COVID-19 pandemic highlighted the vulnerability of immunocompromised patients to severe outcomes, as well as the potential role of such individuals in sustaining viral transmission.

Mechanisms by which immunodeficiency influences emerging infectious diseases

Increased susceptibility: Immunodeficient individuals are more prone to infections due to their inability to mount an effective immune response. This vulnerability can amplify disease transmission, particularly in the case of pathogens that are readily spread in close contact settings.

Pathogen evolution: Pathogens can adapt to evade immune responses, especially in immunocompromised hosts where selective pressures are different. Over time, this can result in the emergence of new strains with enhanced survival mechanisms.

Prolonged infections and viral shedding: Immunodeficient hosts may experience longer durations of infection, leading to persistent viral shedding and increased opportunities for transmission within communities. This is of particular concern in the context of global travel, where individuals may spread infectious diseases across borders.

Vaccine efficacy: Immunodeficient individuals often respond poorly to vaccines, reducing herd immunity and increasing the risk of outbreaks [4]. In the case of live attenuated vaccines, there is also the potential risk of vaccine-derived infections, further complicating control efforts.

Immunodeficiency and specific emerging pathogens

HIV/AIDS and tuberculosis (TB): People with HIV/AIDS are at increased risk for TB infection and its reactivation. The immunocompromised state of HIV-positive individuals creates a fertile environment for TB to thrive and spread [5].

COVID-19 and immunosuppressed populations: During the COVID-19 pandemic, people with immunodeficiency were disproportionately affected. Studies have shown that immunocompromised individuals not only experience more severe disease outcomes but also have a prolonged viral shedding period, raising concerns about viral persistence and the potential for new variants to emerge.

Fungal infections: Immunocompromised individuals are more susceptible to opportunistic fungal infections such as invasive aspergillosis or candidiasis, which are rare in healthy populations but pose significant risks in hospitals or post-transplant settings [6].

Conclusion

Immunodeficiency plays a pivotal role in shaping the dynamics of emerging infectious diseases. Immunocompromised individuals are more susceptible to infections, often experience more severe disease outcomes, and can inadvertently contribute to the persistence and evolution of pathogens. As the global population continues to age, and the use of immunosuppressive therapies increases, understanding the role of immunodeficiency in EIDs is critical to developing effective public health strategies. This includes tailored vaccination programs, surveillance for prolonged infections, and the management of immunodeficient populations during outbreaks. Addressing these challenges will be essential for mitigating the risks posed by emerging infectious diseases in the future.

Acknowledgement

None

Conflict of Interest

None

References

1. Brinjikji W, Luetmer PH, Comstock B, Bresnahan BW, Chen LE (2015) Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol 36: 811-816.

Indexed at, Google Scholar, Crossref

2. Ma Y, Liang L, Zheng F, Shi L, Zhong B (2020) Association Between Sleep Duration and Cognitive Decline. JAMA Netw Open 3: 2013573.

Indexed at, Google Scholar, Crossref

3. Mathus-Vliegen EMH (2012) Obesity and the elderly. J Clin Gastroenterol 46: 533-544.

Indexed at, Google Scholar, Crossref

4. Kim K, Yaffe K, Rehkopf DH, ZhengY, Nannini DR (2023) Association of Adverse Childhood Experiences With Accelerated Epigenetic Aging in Midlife. JAMA Netw Open 6: e2317987.

Indexed at, Google Scholar, Crossref

5. Peracino A (2014) Hearing loss and dementia in the aging population. Audiol Neurootol 1: 6-9.

Indexed at, Google Scholar, Crossref

6. Zhang J (2021) Dietary Diversity and Healthy Aging: A Prospective Study. Nutrients 13: 1787.

Indexed at, Google Scholar, Crossref